Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003220 · ClinicalTrials.gov registry record · Phase 2
Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
A Phase 2 study, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00003220: Completed Phase 2 study, sponsored by Barbara Ann Karmanos Cancer Institute.
NCT00003220 is a Phase 2 study that has completed, run by Barbara Ann Karmanos Cancer Institute. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003220, a Phase 2 study, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients with metastatic colorectal cancer.
Interventions
- DRUG bryostatin 1
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-02 |
| Est. Completion | 2001-06 |
| Phase | Phase 2 |
What the finished NCT00003220 record still lists
NCT00003220 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which bryostatin 1 is the first listed.
NCT00003220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003220 about?
NCT00003220 is a clinical study titled "Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients with metastatic colorectal cancer.
What is the current status of trial NCT00003220?
This trial is currently completed. It is a Phase 2 study. The study started on 1998-02. Estimated completion is 2001-06.
What interventions are being tested in trial NCT00003220?
The interventions under investigation include: bryostatin 1 (DRUG).
Who is sponsoring clinical trial NCT00003220?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia